S&P 500 Healthcare Sector SEC Filings — April 24, 2026

24-04-2026

Ponce Financial Group reported Q1 2026 net income available to common stockholders of $8.3 million ($0.36 per diluted share), down 16% QoQ from $9.9 million ($0.42 per share) in Q4 2025 but up 46% YoY from $5.7 million ($0.25 per share) in Q1 2025. Net interest income increased 1.05% QoQ and 27.13% YoY to $28.2 million with net interest margin expanding 4bps QoQ and 63bps YoY to 3.61%, supported by 3.82% loan growth and 4.26% deposit growth QoQ to $2.70 billion and $2.13 billion respectively; however, non-interest income declined 41.3% QoQ to $2.0 million, non-interest expense rose 3.64% QoQ to $17.2 million, and efficiency ratio worsened to 56.96%. Total assets grew 2.38% QoQ to $3.30 billion, non-performing loans improved to 0.62% of total assets, but cash equivalents fell 7.06% QoQ.

• ·Provision for credit losses on loans: $1.7M in Q1 2026, up from $1.1M in Q4 2025
• ·Total capital ratio (Company): 21.23% as of March 31, 2026, down from 23.00% as of Dec 31, 2025
• ·Return on average assets: 1.07% in Q1 2026, down from 1.26% in Q4 2025
• ·Book value per share: $13.49 as of March 31, 2026, up 12% YoY
• ·Cumulative deep impact lending: 82% after 15 quarters including Q1 2026

24-04-2026

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) announced a registered direct offering of 5,076,143 shares of common stock (or pre-funded warrants) at $0.985 per share, priced at-the-market under Nasdaq rules, expected to generate approximately $5 million in gross proceeds before deducting fees. In a concurrent private placement, the company will issue unregistered warrants to purchase up to 5,076,143 shares at an exercise price of $0.86 per share, exercisable immediately and expiring five years after registration statement effectiveness. Net proceeds will support the LYMPHIR™ commercial launch, milestone/regulatory payments, development of product candidates like Mino-Lok® and Halo-Lido, and general corporate purposes.

• ·Closing expected on or about April 24, 2026, subject to customary conditions.
• ·LYMPHIR™ launched by Citius Oncology in December 2025 for relapsed or refractory Stage I–III CTCL.
• ·Shelf registration statement (File No. 333-277319) filed February 23, 2024, effective March 1, 2024.
• ·Pivotal Phase 3 trial for Mino-Lok® and Phase 2b for Halo-Lido completed in 2023; Mino-Lok® met primary/secondary endpoints.

24-04-2026

BV Financial, Inc. issued an errata sheet for its 2026 annual meeting proxy statement, correcting footnotes 2-5, 7-8, 10, and 11 in the stock ownership table for directors and executives (totals unchanged), board committee memberships, and the board's director nomination recommendation wording. It also fixed an error in the March 26, 2026 CEO shareholder letter, stating the August 29, 2018 stock price as $7.19 (not adjusted to $4.71), resulting in a seven-year CAGR of approximately 13% instead of 20%. Ownership details reflect 8,790,568 shares outstanding as of March 13, 2026, with insiders holding 1,413,686 shares or 15.69%.

• ·Corrected Audit Committee: William Streett Baldwin (Chair), William B. Crompton, Machteld V. Thomas.
• ·Corrected Compensation Committee: Gary T. Amereihn (Chair), William Streett Baldwin, Brian McHale.
• ·Corrected Governance and Nominating Committee: Joshua W. Posnick (Chair), Machteld V. Thomas, William B. Crompton.
• ·Board recommendation corrected to: 'The Board of Directors of the Company recommends a vote “FOR” each nominee for director.'
• ·Proxy statement originally mailed on or about April 2, 2026.

24-04-2026

Flagstar Bank reported Q1 2026 net income of $21 million, down from $29 million in Q4 2025 but a turnaround from a $100 million loss in Q1 2025, with net income attributable to common stockholders at $13 million ($0.03/share) versus $21 million prior quarter. Strong C&I loan growth of $1.4 billion (9% QoQ) to $16.6 billion and core deposits up $1.1 billion (2%) were offset by overall loans down 1% QoQ to $60.4 billion, total deposits up only 1% to $66.8 billion, and net interest income down 5% to $443 million. Credit quality improved with non-accrual loans down 11% and CET1 ratio up to 13.24%, though NCOs rose to 0.52% (0.29% adjusted).

• ·Provision for credit losses was zero in Q1 2026 vs. $3M in Q4 2025 and $79M in Q1 2025.
• ·Net charge-offs totaled $78M in Q1 2026, including $34M from one resolved borrower relationship.
• ·Fitch and Moody's upgraded several Bank ratings to investment grade earlier in Q1 2026.
• ·Tangible book value per share $17.42 ($15.70 adjusted for warrant exercise).

24-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 24, 2026, announcing the issuance of a press release titled 'AITX's RAD Wins 16 Unit ROSA Order for Multi-Site Construction Deployment.' The press release, attached as Exhibit 99.1, highlights a new order for 16 ROSA units from RAD for deployment across multiple construction sites, signaling demand for AITX's AI security solutions.

• ·Filing under Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Information furnished, not filed, per Item 8.01

24-04-2026

News Corporation filed an 8-K on April 24, 2026, disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A and Class B common stock, as required under ASX rules. The disclosures are attached as Exhibits 99.1 and 99.2, with no specific repurchase transactions detailed in the filing itself. This represents routine compliance reporting with forward-looking statements about potential future repurchases subject to market conditions.

• ·Filing covers Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• ·Securities: Class A Common Stock (NWSA) and Class B Common Stock (NWS) on Nasdaq Global Select Market.
• ·Date of earliest event reported: April 23, 2026.

24-04-2026

Lucid Group, Inc. (LCID) issued a DEFA14A notice for its virtual Annual Meeting of Stockholders on June 4, 2026, at 9:00 a.m. Pacific Time. Key proposals include the election of nine director nominees, ratification of KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, advisory approval of named executive officer compensation, and approval of the amendment and restatement of the 2021 Stock Incentive Plan, with the Board recommending a vote FOR all items. Proxy materials are available online at www.proxydocs.com/LCID, and paper copies can be requested by May 23, 2026.

• ·Proxy materials request deadline: May 23, 2026
• ·Voting available online at www.proxypush.com/LCID 24/7
• ·Paper copy requests via www.investorelections.com/LCID, phone 866-870-3684, or email paper@investorelections.com

24-04-2026

DiPaolo Financial Group, Inc. filed its 13F-HR report for the period ended March 31, 2026, disclosing a portfolio of 45 holdings valued at $137398476 across ETFs and equities. Top positions include Vanguard Tax-Managed Fds Van FTSE Dev Mkt (21146173 value), Vanguard Index Fds Growth ETF (19126430), and Vanguard Index Fds Value ETF (17580221), with notable stock holdings in Apple Inc. (1183756, 4664 shares) and Dimensional ETF Trust US Small Cap ETF (4464018, 62759 shares). The filing reports sole discretion on all positions with no indicated changes.

• ·Filed on April 24, 2026; report period end March 31, 2026
• ·All holdings under sole voting authority and discretion
• ·Business address: 4635 Van Dyke Road, Lutz, FL 33558
• ·CIK: 0002111462

24-04-2026

First American Financial Corp (FAF) reported Q1 2026 revenues of $1,838.0 million, up 16.2% YoY from $1,582.3 million, with direct premiums up 17.6% to $660.2 million, agent premiums up 16.0% to $759.4 million, and net investment income up 12.7% to $152.4 million. Net income attributable to the Company rose 68.6% YoY to $125.1 million, with diluted EPS increasing to $1.21 from $0.71. However, comprehensive income attributable to the Company declined sharply to $59.3 million from $170.8 million due to $65.8 million in other comprehensive losses, mainly from unrealized losses on debt securities, and total assets grew to $17,936.6 million while stockholders' equity was slightly down 0.2% to $5,489.6 million.

• ·Cash provided by operating activities was $5.6 million in Q1 2026, improved from ($52.8 million) in Q1 2025 but remained low.
• ·Share repurchases totaled $33.5 million in Q1 2026.
• ·Cash dividends paid $56.2 million in Q1 2026.
• ·Net investment losses were $9.1 million in Q1 2026 versus $10.8 million in Q1 2025.

24-04-2026

Foronjy Financial LLC reported its quarterly 13F-HR holdings as of March 31, 2026, totaling $240,559,400 across 97 positions, all held solely on a discretionary basis with no other managers reported. The portfolio features significant allocations to fixed income and Treasury ETFs such as iShares 3-7 Year Treasury Bond ETF ($16,266,780) and Invesco 30 Corporate Credit ETF ($16,112,519), alongside equity stakes in tech leaders including Apple Inc. ($1,075,670), Nvidia Corporation ($849,501), and Vanguard Information Technology ETF ($15,806,517). No period-over-period changes or performance metrics are disclosed in this routine holdings snapshot.

• ·All 97 positions held as sole discretionary with sole voting authority.
• ·No non-discretionary accounts or directed voting authority reported.
• ·Filing submitted April 24, 2026; period end March 31, 2026.
• ·Filer CIK: 0002040600; based in California.

24-04-2026

Fortitude Financial, LLC filed a 13F-HR report on April 24, 2026, disclosing total holdings of $188,981,174 as of March 31, 2026, across 39 positions with no changes reported from the prior quarter. The portfolio is diversified across ETFs and individual stocks, with the largest holding being SPDR S&P 500 ETF TR UNIT (112,861 shares valued at $73,398,023), followed by SPDR SERIES TRUST STATE STREET SPD (78464A409, 222,230 shares valued at $21,758,521) and SPDR SERIES TRUST STATE STREET SPD (78464A854, 211,706 shares valued at $16,203,977). Other notable positions include Apple Inc. (1,445 shares, $366,727), Amazon.com Inc. (1,970 shares, $410,292), Microsoft Corp. (1,562 shares, $578,206), and Nvidia Corporation (3,121 shares, $544,302).

• ·Filing date: April 24, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported as sole voting authority (SH SOLE)
• ·Firm address: 123 E 2nd Ave Suite A, Spokane, WA 99202

24-04-2026

Jones Kertz & Associates, Inc., an investment advisor based in Blaine, MN, filed its 13F-HR report on April 24, 2026, disclosing $188341537 in equity holdings across 66 positions as of March 31, 2026, all held solely. Top holdings by market value include Broadcom Inc. at $14124179 (45634 shares), Apple Inc. at $14058443 (55394 shares), and KLA Corp at $11643818 (7908 shares). The filing provides a snapshot of the firm's portfolio with no period-over-period changes reported.

• ·Filing effective date: April 24, 2026
• ·Report period end: March 31, 2026
• ·Business address: 9298 Central Ave NE, Suite 210, Blaine, MN 55434

24-04-2026

On April 23, 2026, Jefferies Financial Group Inc. announced the pricing of its public offering of $1,100,000,000 aggregate principal amount of 5.125% Senior Notes due 2031 via a Pricing Press Release (Exhibit 99.1). This debt issuance provides the company with additional long-term financing. No comparative financial metrics or performance declines were reported.

• ·Filing signed by Michael J. Sharp on April 23, 2026.
• ·Securities registered on New York Stock Exchange under symbols JEF, JEF 27A, JEF 28, JEF 32A, JEF 34, JEF36.

24-04-2026

Embree Financial Group filed its 13F-HR on April 24, 2026, disclosing total holdings of $849163395 across 265 positions as of March 31, 2026. The portfolio consists primarily of ETFs and large-cap stocks, with top holdings including Invesco QQQ Trust ($58441093), SPDR S&P 500 ETF Trust ($48100306), Apple Inc. ($36414725), iShares Core S&P Total U.S. Stock Market ETF ($36492443), and Putnam Focused Large Cap Value ETF ($35495158). All positions are reported as solely owned with sole voting authority, including minor call options in select names.

• ·Small call option positions reported in EOS Energy Enterprises Inc. (16100 SH SOLE), Figma Inc. (70578 SH SOLE), PureCycle Technologies Inc. (14400 SH SOLE), and SPDR Gold Trust (100 SH Call SOLE)
• ·Investment discretion: 0% put/call, 100% sole voting authority across all positions
• ·Filer CIK: 0002020860, SEC file number: 028-24082

24-04-2026

Vest Financial, LLC filed its 13F-HR on April 24, 2026, disclosing equity holdings as of March 31, 2026, across numerous U.S. and international public companies held on a defined (DFND) or sole discretionary (SOLE) basis. Top positions include Automatic Data Processing Inc. (408133 DFND shares valued at 82924462 USD), Abbott Laboratories (738830 DFND shares at 75855676 USD), and Alphabet Inc. Cl A (241441 DFND shares at 69428775 USD). The filing lists over 200 individual security positions with no prior period comparison provided.

• ·Filing period end date: March 31, 2026
• ·Filer CIK: 0001709632
• ·SEC file number: 028-20621
• ·Business address: 8350 Broad Street, Suite 240, McLean, VA 22102
• ·Phone: 855-979-6060

24-04-2026

Woori Financial Group Inc. (WFG) is advancing its share exchange transaction to convert Tongyang into a wholly-owned subsidiary, issuing 8,696,875 newly registered common shares based on an exchange price of Won 34,589 (base date April 23, 2026), following approval by a special committee of seven independent non-executive directors and third-party valuation confirming fairness. The record date is set for May 6, 2026, with the expected share exchange date of August 11, 2026, under expedited FHCA provisions, though schedules may adjust based on SEC Form F-4 review. Termination is possible if Tongyang's appraisal rights exceed Korean Won 200 billion or other material adverse events occur.

• ·Special committee assented to share exchange ratio within third-party valuation range, confirming no infringement on minority shareholders.
• ·No WFG shares allocated for Tongyang's pre-existing treasury shares, which will be cancelled; fractional shares paid in cash.
• ·Tongyang to delist from KRX KOSPI post-exchange.
• ·Prior disclosures: dated March 17, 2026, and April 16, 2026.

24-04-2026

CIBRA Capital Ltd filed its Form 13F-HR on April 24, 2026, disclosing total equity holdings of $207,207,070 as of March 31, 2026, across 25 positions all held with sole voting power and no reported shared power, puts, or calls. Largest holdings include Amicus Therapeutics Inc ($24,403,578), Sealed Air Corp ($21,640,444), TXNM Energy Inc ($16,570,955), Masimo Corp ($16,075,179), and Hologic Inc ($15,798,008). The filing provides a snapshot of the firm's U.S. equity portfolio with no period-over-period comparisons available.

• ·All 25 holdings reported with sole voting power (SH SOLE) and zero shared voting power, zero put options, zero call options
• ·Firm CIK: 0002060725; SEC file number: 028-25462
• ·Business address: 1 Lyric Square, CIBRA Capital Ltd, London X0 W6 0NB
• ·Conformed period of report: 03-31-2026

24-04-2026

Union Carbide Corporation reported total net sales of $989M for Q1 2026, up 1.1% YoY from $978M, with net trade sales down slightly to $29M from $30M while sales to related companies rose to $960M from $948M. The net loss narrowed to $79M from $82M YoY, but cost of sales increased to $1,068M from $1,064M, operating cash flow fell sharply to $9M from $38M, and stockholder's equity declined to $1,953M from $2,016M QoQ. Total assets grew modestly to $4,575M from $4,524M at year-end 2025.

• ·Asbestos-related payments remained flat at $24M in Q1 2026 vs Q1 2025.
• ·Cash and cash equivalents flat at $11M.
• ·Inventories flat at $277M vs $278M QoQ.
• ·Depreciation increased to $38M from $31M YoY.

24-04-2026

ChoiceOne reported net income of $13,704,000 for Q1 2026, a slight 1.2% decline QoQ from $13,867,000 but a significant turnaround from a $13,906,000 net loss in Q1 2025, with diluted EPS of $0.91 versus $0.92 and -$1.29. Net interest margin improved to 3.63% from 3.59% QoQ and deposits excluding brokered grew $68.9 million or 7.9% annualized QoQ, however core loans declined $30.9 million or 4.2% annualized QoQ and grew only 0.3% over the prior 12 months, while nonperforming loans rose to 1.01% from 0.98%. Asset quality remained strong with annualized net charge-offs at 0.01%.

• ·Exited $351.0 million pay-fixed interest rate swaps, realizing $4.6 million gain to be amortized over six years.
• ·ChoiceOne Bank total risk-based capital ratio 12.9% as of March 31, 2026, up from 11.9% March 31, 2025.
• ·Uninsured deposits $1.1 billion or 30.7% of total deposits March 31, 2026.
• ·New full-service branch and lending office planned in Troy, MI later in 2026.
• ·Remaining share repurchase authorization: 300,272 shares as of March 31, 2026.

24-04-2026

24-04-2026

Acorn Financial Advisory Services Inc/Adv filed its 13F-HR on April 24, 2026, disclosing 215 equity holdings totaling $729,823,615 as of March 31, 2026. The portfolio is heavily weighted toward ETFs, with top positions including iShares Core U.S. Aggregate Bond ETF at $53,235,147, Vanguard S&P 500 ETF at $42,115,292, and PIMCO ETF TR Multisector Bond at $39,471,531. All reported holdings are sole discretionary with no other voting authority or put/call options exercised.

• ·Filing CIK: 0001018561
• ·SEC File Number: 028-19688
• ·Business address: 1900 Campus Commons Dr. Suite 600, Reston VA 20191
• ·Phone: 703-293-3100

24-04-2026

Goldstone Financial Group, LLC filed its 13F-HR report on April 24, 2026, disclosing $922,268,276 in total holdings across 229 positions as of March 31, 2026, all held with sole voting and discretionary authority. Top holdings include First Trust Exchange-Traded Fund VI Smith Unconstrained ($6,310,106), SPDR Series Trust State Street SPD ($2,718,870), and McDonald's Corp ($1,371,773). No changes from prior periods or performance metrics are detailed in this snapshot filing.

• ·Filed as of April 24, 2026
• ·Report period end: March 31, 2026
• ·All positions reported with sole voting authority and no shared discretion
• ·CIK: 0002040021
• ·No put or call options beyond minor positions

24-04-2026

Mann Financial Group, Inc. filed its 13F-HR report disclosing $106,208,280 in total holdings as of March 31, 2026, across 31 positions primarily consisting of ETFs and individual stocks held solely. Largest holdings include iShares Core S&P 500 ETF at $39,178,229 (59,978 shares), iShares Core MSCI EAFE ETF at $22,080,720 (243,905 shares), and iShares Core U.S. Aggregate Bond ETF at $13,385,391 (134,838 shares). No period-over-period changes or performance metrics are provided in the filing.

• ·Filing date: April 24, 2026
• ·Report period end: March 31, 2026
• ·All positions held as sole discretionary accounts
• ·Contact: Brian Mann, Detroit Lakes, MN

24-04-2026

The JPMBB Commercial Mortgage Securities Trust 2015-C32 failed to make a required distribution to Certificateholders on the April 17, 2026 Distribution Date, as reported under Item 6.04. However, following notification on April 21, 2026, of funds from the late payoff of the Premiere Place Mortgage Loan (Loan Number 27), an additional principal payment of $8,866,050.29 was made to Class A-5 Certificateholders on April 23, 2026. This event highlights an initial distribution shortfall remedied shortly thereafter.

• ·Prospectus supplement filed October 29, 2015 pursuant to Rule 424(b)(5), referencing Loan Number 27 on Annex A-1
• ·Certificate Administrator notified by Master Servicer on April 21, 2026

24-04-2026

Greater Midwest Financial Group, LLC disclosed 65 equity and ETF holdings totaling $186.1 billion in its 13F-HR filing as of March 31, 2026. Top positions include Microsoft Corp ($11.9B), Alphabet Inc Cl A ($10.1B), and Amazon.com Inc ($8.3B), with all holdings reported under sole investment discretion. The filing contains no period-over-period comparisons or changes from prior quarters.

• ·Report period end: March 31, 2026
• ·Filing date: April 24, 2026
• ·All holdings designated as SOLE discretionary with 0 shared discretion, 0 other manager, and 0 voting authority other than sole

24-04-2026

Riverview Bancorp, Inc. announced that Bradley J. Carlson, a director on the boards of the Company and its subsidiary Riverview Bank since December 2014 (elected in 2015), will not stand for re-election at the 2026 Annual Meeting and intends to resign from those boards effective April 23, 2026. The departure is not due to any disagreement with the Company's operations, policies, or practices. Mr. Carlson will continue serving on the board of Riverview Trust Company, a wholly-owned subsidiary of Riverview Bank.

• ·Mr. Carlson served four consecutive terms on the boards since formal election at the 2015 Annual Meeting.
• ·Announcement made on April 24, 2026.

24-04-2026

TCW Specialty Lending LLC filed an 8-K/A amendment on April 24, 2026, to the original 8-K dated April 7, 2026, solely to provide an unaudited schedule of transferred investments as of April 1, 2026, related to a transaction described in the original filing. No other changes were made to the original 8-K. Exhibit 99.1 contains the unaudited schedule.

• ·Original 8-K filed on April 7, 2026
• ·Date of earliest event reported: April 1, 2026
• ·Exhibit 99.1: Unaudited Schedule of Transferred Investments, as of April 1, 2026

24-04-2026

Senti Biosciences, Inc. entered into an Amended and Restated Designation Agreement with Celadon Partners SPV 24 following a reorganization merger on April 24, 2026, where Senti became a wholly-owned subsidiary of Senti Biosciences Holdings, Inc., with each share of Senti common stock converting 1:1 into shares of Holdings common stock. The agreement sets the board size at 8 directors for both entities, names initial directors including Edward Mathers, Frances Schulz, Brenda Cooperstone, James Collins, Timothy Lu, Donald Tang, Feng Hsiung, and Bryan Baum, and grants the Investor rights to designate up to 3 directors (2 non-independent, 1 independent) as long as it beneficially owns at least 2,666,500 shares. Additional provisions include information rights and committee participation opportunities for Investor designees, subject to standard governance approvals.

• ·Investor initial designees: Donald Tang and Bryan Baum (Class II, non-independent), Feng Hsiung (Class III, independent).
• ·Investor information rights include board materials and access to books/records while owning >5% of outstanding shares (assuming full Warrant exercise).
• ·Rights terminate if Investor ownership falls below Requisite Shares; board subject to NCGC approval, independence rules, and stockholder election post-initial term.

24-04-2026

First Business Financial Services, Inc. (FBIZ) reported net income of $12.2M for Q1 2026, up 9% YoY from $11.2M, driven by 7% YoY growth in net interest income to $35.5M and 16% increase in non-interest income to $8.8M. Total assets expanded 6% QoQ to $4.32B, supported by 4% loan growth to $3.46B and 5% deposit growth to $3.57B. However, non-interest expenses rose 9% YoY to $27.0M due to higher compensation costs, provision for credit losses increased 11% to $3.0M, and gain on SBA loan sales declined 38% to $0.6M.

• ·Basic and diluted EPS of $1.44 for Q1 2026, up from $1.32 YoY.
• ·Dividends declared per common share $0.34 for Q1 2026, up from $0.29.
• ·Allowance for credit losses $36,631 thousand as of March 31, 2026, up from $35,877 thousand.
• ·Treasury stock purchases of 13,906 shares in Q1 2026 at cost of $811 thousand.

24-04-2026

PNC Financial Services Group, Inc. held its annual shareholder meeting on April 22, 2026, where all 13 director nominees were elected with strong support ranging from 94.30% to 99.64% For votes. Shareholders also ratified PricewaterhouseCoopers LLP as the independent auditor for 2026 (98.17% For), approved named executive officer compensation on an advisory basis (93.56% For), and approved the 2026 Omnibus Equity Incentive Plan (96.64% For), which authorizes 28,000,000 shares plus unused shares from the 2016 plan. Voting represented approximately 403,516,196 entitled votes with no significant opposition.

• ·Record date for voting: January 30, 2026
• ·Proxy statement filed: March 11, 2026
• ·Board approved Plan: March 5, 2026
• ·Broker non-votes: 36,699,490 across most proposals

24-04-2026

Regeneron Pharmaceuticals, Inc. (REGN) filed Definitive Additional Proxy Soliciting Materials (DEFA14A) on April 24, 2026, as part of Schedule 14A under the Securities Exchange Act of 1934. The filing includes standard company metadata such as CIK 0000872589, SIC 2834 (Pharmaceutical Preparations), and headquarters at 777 Old Saw Mill River Road, Tarrytown, NY. No financial metrics, performance data, or specific proxy proposals are discernible in the provided content due to encoding artifacts.

• ·Filing Type: DEFA14A
• ·Filed as of Date: April 24, 2026
• ·State of Incorporation: NY
• ·Fiscal Year End: 1231
• ·EIN: 133444607
• ·SEC File Number: 000-19034

24-04-2026

Webster Financial Corp's 2025 financials showed strong Net Income growth of 30.4% YoY to $1,002.8 million from $768.7 million, with Total Stockholder Return (TSR) at 175.85 outperforming the peer group TSR of 152.71. However, Adjusted PPNR grew modestly 4.5% YoY to $1,478.1 million from $1,415.0 million, while CEO compensation actually paid increased 64.7% to $9,822,275 aligned with performance. ROE stood at 10.70% and ROAA at 1.23%.

• ·PPNR of $1,470.1 million before adjustments for 2025.
• ·Non-interest expense of $1,429.3 million for 2025.
• ·60% of long-term equity program is performance-based.
• ·Robust stock ownership guidelines reviewed annually; no hedging, pledging, or repricing allowed.

24-04-2026

Federal Home Loan Bank of San Francisco reported Q1 2026 net income of $64 million, down $30 million or 32% YoY from $94 million, due to a $23 million drop in non-interest income and a $17 million increase in voluntary housing contributions despite slightly lower net interest income of $140 million (vs $142 million). Total assets fell to $70.7 billion from $73.3 billion at December 31, 2025, driven by a $1.9 billion reduction in short-term investments. Positively, the Bank paid a $75 million special dividend, declared quarterly dividends at annualized rates of 4.75% to 10.00%, and maintained a strong regulatory capital ratio of 10.22%.

• ·Non-interest expense increased $9 million YoY to $47 million, driven by $17 million higher voluntary contributions offset by $8 million lower operating expenses.
• ·Provision for credit losses was $0 in Q1 2026 vs $1 million in Q1 2025.
• ·Dividends declared on April 23, 2026, payable May 8, 2026, including 8.75% annualized on pre-conversion Class B stock.

24-04-2026

Caribou Biosciences, Inc. has issued a DEFA14A filing for its 2026 Annual Meeting on June 17, 2026, held virtually, where shareholders will vote on electing three Class II directors (Andrew Guggenhime, David Johnson, Nancy Whiting) to serve until the 2029 annual meeting, ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and approving an amendment to the certificate of incorporation for officer exculpation from certain fiduciary duties. The board recommends voting 'For' all proposals, including a potential adjournment if needed for quorum or solicitation on Proposal 3. No financial performance metrics are discussed.

• ·Annual Meeting: June 17, 2026 at 7:30 a.m. Pacific Daylight Time, virtually at www.virtualshareholdermeeting.com/CRBU2026
• ·Vote deadline: June 16, 2026 11:59 PM EDT at www.ProxyVote.com
• ·Request proxy materials by June 3, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
• ·Company address: 2929 7th Street Suite 105, Berkeley, CA 94710

24-04-2026

MetroCity Bankshares reported Q1 2026 net income of $22.3 million, up 21.9% QoQ from $18.3 million and 36.9% YoY from $16.3 million, driven by higher interest income and expanded net interest margin of 4.08%. Loans increased 27.7% YoY to $4.00 billion and deposits rose 32.5% YoY to $3.63 billion; however, QoQ loans declined 1.2%, total assets fell 1.7% to $4.7 billion, deposits dipped slightly, and noninterest income decreased 18.7%. Asset quality strengthened with nonperforming assets at 0.37% of total assets and a $813,000 credit loss recovery.

• ·Efficiency ratio of 42.16% in Q1 2026, improved from 46.71% in Q4 2025 but higher than 38.32% in Q1 2025.
• ·Noninterest-bearing deposits at 22.0% of total deposits, up from 21.4% QoQ and 19.7% YoY.
• ·Allowance for credit losses at 0.66% of total loans, down slightly QoQ but up YoY; 166.15% of nonperforming loans.
• ·SBA loan sales of $19.7 million at 7.68% premium in Q1 2026 vs $9.7 million at 7.13% in Q4 2025.
• ·Mortgage loan originations $101.9 million in Q1 2026, down from $111.7 million in Q4 2025 with no sales.

24-04-2026

Bayview Acquisition Corp's securities were transferred to The Nasdaq Capital Market effective April 24, 2026, following a Nasdaq Hearings Panel decision granting continued listing after an appeal of a delisting notice. The continued listing is conditional on closing the business combination with Oabay Inc. by June 19, 2026, and demonstrating compliance with Nasdaq's initial listing rules, with no assurance of success and potential for Panel reconsideration. The transfer is not expected to materially impact trading, which continues under symbols BAYA, BAYAU, and BAYAR.

• ·Nasdaq delisting notice received February 19, 2026
• ·Application to transfer listing submitted December 16, 2025
• ·Hearing conducted March 31, 2026
• ·Panel Decision issued April 22, 2026
• ·Option to appeal to Nasdaq Listing and Hearing Review Council within 15 days

24-04-2026

First Western Financial Inc (MYFW) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Shareholders on June 3, 2026, at 4:00 pm MT in Denver, CO, seeking to elect 11 directors, ratify Crowe LLP as independent auditors for the year ending December 31, 2026, and approve a non-binding 'Say on Pay' vote on named executive officer compensation. The record date is April 10, 2026, and the statement references a review of 2025 operating results but provides no specific financial metrics. No period-over-period comparisons or performance data are detailed in the filing.

• ·Record date: April 10, 2026
• ·Annual meeting location: 1900 Sixteenth Street, Suite 1200, Denver, Colorado 80202
• ·Proxy materials available at www.proxyvote.com
• ·References 2025 Annual Report and Form 10-K for year ended December 31, 2025

24-04-2026

Citizens Financial Group, Inc. held its 2026 Annual Meeting of Stockholders on April 23, 2026, where all 11 director nominees were elected with majority support ranging from approximately 336M to 357M shares for. Stockholders also approved the advisory vote on executive compensation (327M for) and ratified Deloitte & Touche LLP as the independent public accounting firm for 2026 (355M for). However, the shareholder proposal for adoption of a majority voting standard was rejected, with 321M shares against.

• ·Broker non-votes: 26,316,510 shares for proposals 1, 2, and 4; none for proposal 3.
• ·Notable opposition in director elections: Bruce Van Saun (20,362,054 against), Edward J. Kelly III (16,011,559 against), Marita Zuraitis (11,579,895 against).
• ·Advisory vote on executive compensation: 30,630,016 against, 1,141,219 abstain.
• ·Auditor ratification: 29,398,633 against, 396,887 abstain.

24-04-2026

Maravai LifeSciences Holdings, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting seeks election of three Class III directors (Bernd Brust, Gregory T. Lucier, Luke Marker) to serve until 2029, following a board size reduction from 11 to 8 members since the 2025 annual meeting. It outlines governance practices, director qualifications, and GTCR's ongoing nomination rights under the Director Nomination Agreement tied to their ownership thresholds. Deadlines for 2027 shareholder proposals include December 25, 2026 for SEC Rule 14a-8 inclusion, with nomination notices required between January 26 and February 25, 2027, and universal proxy notices by March 27, 2027.

• ·Principal executive offices: 10770 Wateridge Circle Suite 200, San Diego, California 92121
• ·Shareholder proposals for 2027 Annual Meeting inclusion under Rule 14a-8: received by Corporate Secretary no later than December 25, 2026
• ·Director nominations/proposals (not for inclusion): no later than close of business February 25, 2027, not earlier than January 26, 2027
• ·Universal proxy notice under Rule 14a-19: no later than March 27, 2027
• ·Assumed 2027 Annual Meeting date: May 26, 2027 (anniversary reference)
• ·Ratification of Deloitte & Touche LLP as independent auditor for year ending December 31, 2026 (Proposal 2, routine matter)
• ·Election of directors (Proposal 1) and advisory vote on executive compensation (Proposal 3) are non-routine
• ·Director ages as of March 27, 2026
• ·GTCR nomination rights scale with ownership: 100% at >=40% of IPO holdings, down to 1 at >=5%

24-04-2026

Root Financial Partners, LLC disclosed its quarterly 13F-HR holdings as of March 31, 2026, reporting 3,466 positions with a total market value of $2,162,276,675. Top holdings include Vanguard Total Stock Market ETF at $38,239,179 (119,196 shares), Amazon.com Inc. at $7,736,025 (37,144 shares), and Invesco QQQ Trust Series I at $4,822,098 (8,355 shares). All positions are held with sole discretionary voting authority, with no prior period comparisons or performance metrics provided in the filing.

• ·Filing date: April 24, 2026
• ·Report period end: March 31, 2026
• ·Business address: 1106 2nd Street Suite 102, Encinitas, CA 92024
• ·All holdings reported with sole voting authority (SH SOLE)
• ·Central Index Key: 0001977181
• ·SEC File Number: 028-23236

24-04-2026

Rallybio Corp's S-4/A filing outlines risks from its proposed merger with Candid, including post-closing SEC restrictions like ineligibility for Form S-3 for 12 months and 'ineligible issuer' status for three years, increasing capital raising costs and resale limitations for affiliates. Financially, net losses narrowed to $9.0M for the year ended December 31, 2025 (from $57.8M in 2024, aided by a $23.0M JV sale gain), but accumulated deficit stands at $302.0M with cash sufficient for at least 12 months; Rallybio CVRs may expire worthless if Legacy Assets are not monetized timely. Ongoing development of RLYB116 requires significant additional capital amid substantial operating losses expected to continue.

• ·Existing cash, cash equivalents, and marketable securities as of Dec 31, 2025 sufficient for at least 12 months beyond April 24, 2026 filing date.
• ·Combined company ineligible for Form S-3 until 12 full calendar months post-Closing; must wait 60 days post-Super 8-K for Form S-8.
• ·Rallybio CVRs are unsecured and subordinated to senior obligations; payments contingent on monetizing Legacy Assets or Recursion proceeds within specified period.

24-04-2026

McEwen Inc. issued a notice for its 2026 Annual Meeting of Shareholders on June 4, 2026, at 4:30 p.m. ET in Toronto, with a webcast option, where shareholders will vote on electing 11 director nominees including Robert R. McEwen, ratifying Ernst & Young LLP as independent auditors for the year ending December 31, 2026, and approving common stock issuance to Robert R. McEwen pursuant to an Arrangement Agreement with Canadian Gold Corp. Proxy materials and the 2025 annual report are available online at www.envisionreports.com/MUX, with paper copy requests due by May 25, 2026. No financial performance metrics are provided in this notice.

• ·Meeting location: 150 King Street West, 27th Floor, Toronto, Ontario M5H 1J9.
• ·Webcast access requires registration at https://vantagevenues.zoom.us/webinar/register/WN_voXdh5dbRSKwcaMLWmV2Yg#/registration.
• ·Annual report covers year ended December 31, 2025.
• ·Board recommends voting FOR all proposals 1, 2, and 3.

24-04-2026

Manhattan Associates, Inc. issued a supplement to its April 2, 2026 proxy statement for the Annual Meeting of Shareholders on May 14, 2026, correcting the number of outstanding shares of Common Stock as of the Record Date, March 18, 2026, to 59,162,073 shares. Existing proxy cards remain valid, and no further action is required from shareholders who have already voted. The supplement does not modify other information in the original proxy statement and urges voting via methods outlined therein.

• ·Record Date: March 18, 2026
• ·Annual Meeting Date: May 14, 2026
• ·Company Address: 2300 Windy Ridge Parkway, Tenth Floor, Atlanta, Georgia 30339

24-04-2026

Lucid Diagnostics Inc. closed an underwritten public offering of 18,000,000 shares of common stock at $1.00 per share, generating expected net proceeds of approximately $16.8 million to be used for working capital and general corporate purposes. Canaccord Genuity LLC and BTIG, LLC acted as joint bookrunners for the offering conducted under an existing shelf registration on Form S-3.

• ·Offering made pursuant to shelf registration statement on Form S-3 (Registration No. 333-291981), filed December 5, 2025, effective March 26, 2026, with prospectus supplement filed April 23, 2026.

24-04-2026

NewAmsterdam Pharma Company N.V. announced on April 20, 2026, that Louise Kooij's employment as Chief Accounting Officer will end effective August 31, 2026, with a separation agreement entered on April 24, 2026. Ms. Kooij is eligible for a lump sum of twelve months' base salary, a pro-rated 2026 annual cash bonus at target achievement through the separation date, and accrued unused holiday and vacation days. The agreement also extends vesting of her outstanding stock options and RSUs to January 10, 2027, and the exercise period for vested options to February 10, 2027, while including restrictive covenants.

• ·Separation Agreement contains confidentiality, non-compete, non-disparagement covenants, and a release of claims.
• ·Separation Agreement to be filed with Quarterly Report on Form 10-Q for quarter ending June 30, 2026.

24-04-2026

Prospect Financial Services LLC filed Form 13F-HR on April 24, 2026, disclosing 104 equity and ETF positions held as of March 31, 2026, with no prior period comparisons provided. Top holdings include Alphabet Inc Cap Stk Cl C at $9.87B, Vanguard Scottsdale Fds LG-Term Cor Bd ETF at $9.46B, SL Green Rlty Corp at $9.32B, Boeing Co at $8.47B, and Invesco QQQ Tr at $6.59B, reflecting a diversified portfolio heavy in tech, REITs, bonds, and energy. The filing reports all positions as sole discretionary with no voting or other rights indicated.

• ·Report period end date: March 31, 2026
• ·Filing date: April 24, 2026
• ·All 104 positions held as sole discretionary (SH SOLE)
• ·Business address: 445 Broad Hollow Road, Ste CL-43, Melville, NY 11747
• ·State of incorporation: NY
• ·Significant REIT exposure: Vornado Rlty Tr ($1.82B), Plains All Amern Pipeline ($1.14B)